Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1980-11-14
1983-04-26
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 15, 424 85, 435 2, 435 7, 435172, 260112R, A61K 4300, A61K 3900, G01N 3354
Patent
active
043812929
ABSTRACT:
Mammalian monoclonal antibodies specific for an antigen diagnostic for thymocytes, normal peripheral T cells and some null cells. The antibodies which distinguish among subpopulations of T cells, find use in assays, cell sorting, and immunosupression.
REFERENCES:
patent: 4196265 (1980-01-01), Koprowski
Eur. J. Immunology 1979, 9:205-210, A. J. McMichael et al., "A Human Thymocyte Antigen Defined by a Hybrid Myeloma Monoclonal Antidoly".
Bieber Charles P.
Howard Frank D.
Moskowitz M.
Padgett Benjamin R.
Rowland Bertram I.
The Board of Trustees of the Leland Stanford Jr. University
LandOfFree
Anti-human T-lymphocyte monoclonal antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-human T-lymphocyte monoclonal antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-human T-lymphocyte monoclonal antibody will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1564304